Samy Suissa

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 57

Top Topics

Atrial Fibrillation

Chronic Obstructive Pulmonary Disease

Systematic Review

Top Venues

Pharmacoepidemiology and drug safety

The European respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Samy Suissa, Fasiha Kanwal
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity? Gut 73 (5) (2024)
Charles Khouri, Samy Suissa
RE: Association of metformin use and cancer incidence: a systematic review and meta-analysis. Journal of the National Cancer Institute 116 (8) (2024)
Samy Suissa, Sebastian Schneeweiss, William B Feldman, Helen Tesfaye, Shirley V Wang
Emulating Randomized Trials by Observational Database Studies: The RCT-DUPLICATE Initiative in COPD and Asthma. American journal of epidemiology (2024)
Samy Suissa, Fasiha Kanwal
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity? Gut (2024)
Richard Chiv, Sarah Beradid, Samy Suissa, Christel Renoux
Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. Stroke 55 (5) (2024)
Samy Suissa, Fasiha Kanwal
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity? Gut 73 (5) (2024)
Karine Suissa, Sophie Dell'Aniello, Eros Comin, Marie Hudson, Samy Suissa
Glucosamine and Cancer Incidence in Osteoarthritis: A Prevalent New-User Cohort Design. Arthritis care & research (2024)
Samy Suissa, Fasiha Kanwal
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity? Gut 73 (5) (2024)
Richard Chiv, Sarah Beradid, Samy Suissa, Christel Renoux
Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. Stroke (2024)
Samy Suissa
Observational studies to emulate randomized trials: Some real-world barriers. British journal of clinical pharmacology 90 (4) (2024)
Karine Suissa, Sophie Dell'Aniello, Eros Comin, Marie Hudson, Samy Suissa
Glucosamine and cancer incidence in osteoarthritis: A prevalent new-user cohort design. Arthritis care & research (2024)
Samy Suissa
Observational studies to emulate randomized trials: Some real-world barriers. British journal of clinical pharmacology 90 (4) (2024)
Samy Suissa, Fasiha Kanwal
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity? Gut 73 (5) (2024)
Samy Suissa
Observational studies to emulate randomized trials: Some real-world barriers. British journal of clinical pharmacology (2024)
Seoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, Deborah J Wexler, Samy Suissa, Julie M Paik, Elisabetta Patorno
Bariatric surgery and all-cause mortality: A methodological review of studies using a non-surgical comparator. Diabetes, obesity & metabolism (2024)
Samy Suissa
Observational studies to emulate randomized trials: Some real-world barriers. British journal of clinical pharmacology 90 (4) (2024)
Samy Suissa
Simplifying pharmacotherapy for patients with COPD: a viewpoint. The European respiratory journal 62 (6) (2023)
Samy Suissa
Simplifying pharmacotherapy for patients with COPD: a viewpoint. The European respiratory journal 62 (6) (2023)
Samy Suissa
Triple therapy in COPD: understanding the data. ERJ open research 9 (1) (2023)
Samy Suissa
Single-inhaler triple versus dual bronchodilator therapy for GOLD E and other exacerbating patients with COPD: Real-world comparative effectiveness and safety. The European respiratory journal (2023)
Samy Suissa
Simplifying pharmacotherapy for patients with COPD: a viewpoint. The European respiratory journal 62 (6) (2023)
Teresa A Simon, Lixian Dong, Samy Suissa, Kaleb Michaud, Sofia Pedro, Marc Hochberg, Maarten Boers, Johan Askling, Thomas Frisell, Anja Strangfeld, Yvette Meißner, Vadim Khaychuk, Alyssa Dominique, Michael A Maldonado
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies. Annals of the rheumatic diseases (2023)
Samy Suissa
Simplifying pharmacotherapy for patients with COPD: a viewpoint. The European respiratory journal 62 (6) (2023)
Oriana Hoi Yun Yu, Samy Suissa
Metformin and Cancer: Solutions to a Real-World Evidence Failure. Diabetes care 46 (5) (2023)
Oriana Hoi Yun Yu, Samy Suissa
Metformin and Cancer: Solutions to a Real-World Evidence Failure. Diabetes care 46 (5) (2023)
Naheemot Olaoluwa Sule, Samy Suissa
Statins and Mortality in COPD: A Methodological Review of Observational Studies. COPD 20 (1) (2023)
Jiaying Li, Sophie Dell'Aniello, Pierre Ernst, Samy Suissa
Real-world comparative effectiveness of three single-inhaler dual bronchodilators for the treatment of chronic obstructive pulmonary disease. The European respiratory journal (2023)
Samy Suissa
Triple therapy in COPD: understanding the data. ERJ open research 9 (1) (2023)
Antonios Douros, Zharmaine Ante, Samy Suissa, Paul Brassard
Common vaccines and the risk of incident dementia: a population-based cohort study. The Journal of infectious diseases (2022)
Karine Suissa, Marie Hudson, Samy Suissa
Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies. Pharmacoepidemiology and drug safety 31 (12) (2022)
Samy Suissa, Sophie Dell'Aniello, Pierre Ernst
Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. COPD 19 (1) (2022)
Gulsen Ozen, Sophie Dell'Aniello, Sofia Pedro, Kaleb D Michaud, Samy Suissa
Reduction of Cardiovascular Disease and Mortality Versus Risk of New-Onset Diabetes Mellitus With Statin Use in Patients With Rheumatoid Arthritis. Arthritis care & research (2022)
Ian Shrier, Samy Suissa
The quintessence of causal DAGs for immortal time bias: time-dependent models. International journal of epidemiology 51 (3) (2022)
Samy Suissa, Sophie Dell'Aniello, Pierre Ernst
Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. COPD 19 (1) (2022)
Sophie Dell'Aniello, Christel Renoux, Samy Suissa
Regarding: Webster-Clark M., et al. Alternative analytic and matching approaches for the prevalent new-user design: a simulation study. Pharmacoepidemiol Drug Saf, 31, pp. 796-803; 2022. Pharmacoepidemiology and drug safety 31 (12) (2022)
Na He, Sophie Dell'Aniello, Suodi Zhai, Samy Suissa, Christel Renoux
Risk of fracture in patients with non-valvular atrial fibrillation initiating direct oral anticoagulants vs. vitamin K antagonists. European heart journal. Cardiovascular pharmacotherapy 7 (5) (2022)
Devin Abrahami, Emily Gibson McDonald, Mireille E Schnitzer, Alan N Barkun, Samy Suissa, Laurent Azoulay
Proton pump inhibitors and risk of colorectal cancer. Gut 71 (1) (2021)
Samy Suissa, Karine Suissa, Marie Hudson
Effectiveness of Allopurinol in Reducing Mortality: Time-Related Biases in Observational Studies. Arthritis & rheumatology (Hoboken, N.J.) 73 (9) (2021)
Devin Abrahami, Emily Gibson McDonald, Mireille E Schnitzer, Alan N Barkun, Samy Suissa, Laurent Azoulay
Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut 71 (1) (2021)
Samy Suissa, Karine Suissa, Marie Hudson
Allopurinol and cardiovascular events: Time-related biases in observational studies. Arthritis care & research (2021)
Samy Suissa, Sophie Dell'Aniello, Pierre Ernst
Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality. COPD (2021)
Samy Suissa, Sophie Dell'Aniello, Pierre Ernst
Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study. COPD 18 (1) (2021)
Samy Suissa, Karine Suissa, Marie Hudson
Reply. Arthritis & rheumatology (Hoboken, N.J.) 73 (12) (2021)
Tanja Tran, Martina Šterclová, Nesrin Mogulkoc, Katarzyna Lewandowska, Veronika Müller, Marta Hájková, Mordechai R Kramer, Dragana Jovanović, Jasna Tekavec-Trkanjec, Michael Studnicka, Natalia Stoeva, Karel Hejduk, Ladislav Dušek, Samy Suissa, Martina Vašáková, null null
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis. Respiratory research 21 (1) (2020)
Samy Suissa, Sophie Dell'Aniello
Time-related biases in pharmacoepidemiology. Pharmacoepidemiology and drug safety 29 (9) (2020)
Samy Suissa
Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect. Diabetes care 41 (2) (2019)
Robert W Platt, David A Henry, Samy Suissa
The Canadian Network for Observational Drug Effect Studies (CNODES): Reflections on the first eight years, and a look to the future. Pharmacoepidemiology and drug safety (2019)
Antonios Douros, Sophie Dell'Aniello, Oriana Hoi Yun Yu, Samy Suissa
Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort study. Diabetes, obesity & metabolism 22 (2) (2019)
Kristian B Filion, Antonios Douros, Laurent Azoulay, Hui Yin, Oriana H Yu, Samy Suissa
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study. British journal of clinical pharmacology 85 (10) (2019)
Robert W Platt, Richard Platt, Jeffrey S Brown, David A Henry, Olaf H Klungel, Samy Suissa
How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiology and drug safety (2019)
Samy Suissa
Response to Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. Diabetes care 41 (6) (2018)
Samy Suissa, Jeffrey M Drazen
Making Sense of Triple Inhaled Therapy for COPD. The New England journal of medicine 378 (18) (2018)
Samy Suissa, Alain Suissa
Proton-pump inhibitors and increased gastric cancer risk: time-related biases. Gut 67 (12) (2018)
Samy Suissa
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes care 41 (1) (2018)
Christel Renoux, Sophie Dell'Aniello, Benjamin Brenner, Samy Suissa
Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism. Pharmacoepidemiology and drug safety 26 (5) (2017)
Antonios Douros, Christel Renoux, Janie Coulombe, Samy Suissa
Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study. Pharmacoepidemiology and drug safety 26 (12) (2017)
Antonios Douros, Hui Yin, Oriana Hoi Yun Yu, Kristian B Filion, Laurent Azoulay, Samy Suissa
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events. Diabetes care 40 (11) (2017)